Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Autoantigenomics: Holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases.

Moritz CP, Paul S, Stoevesandt O, Tholance Y, Camdessanché JP, Antoine JC.

Autoimmun Rev. 2020 Feb;19(2):102450. doi: 10.1016/j.autrev.2019.102450. Epub 2019 Dec 12. Review.

PMID:
31838165
2.

Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies.

Tholance Y, Moritz CP, Rosier C, Ferraud K, Lassablière F, Reynaud-Federspiel E, França MC Jr, Martinez ARM, Camdessanché JP, Antoine JC; anti-FGFR3 antibody Study Group.

J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):49-57. doi: 10.1136/jnnp-2019-321849. Epub 2019 Nov 5.

PMID:
31690697
3.

[First-episode psychosis as primary manifestation of medical disease: An update].

Goutte J, Killian M, Antoine JC, Massoubre C, Fakra E, Cathébras P.

Rev Med Interne. 2019 Nov;40(11):742-749. doi: 10.1016/j.revmed.2019.07.006. Epub 2019 Aug 14. French.

PMID:
31421899
4.

Relevance of anti-HNK1 antibodies in the management of anti-MAG neuropathies.

Delmont E, Attarian S, Antoine JC, Paul S, Camdessanché JP, Grapperon AM, Brodovich A, Boucraut J.

J Neurol. 2019 Aug;266(8):1973-1979. doi: 10.1007/s00415-019-09367-0. Epub 2019 May 14.

PMID:
31089861
5.

Biallelic MYORG mutation carriers exhibit primary brain calcification with a distinct phenotype.

Grangeon L, Wallon D, Charbonnier C, Quenez O, Richard AC, Rousseau S, Budowski C, Lebouvier T, Corbille AG, Vidailhet M, Méneret A, Roze E, Anheim M, Tranchant C, Favrole P, Antoine JC, Defebvre L, Ayrignac X, Labauge P, Pariente J, Clanet M, Maltête D, Rovelet-Lecrux A, Boland A, Deleuze JF; French PFBC study group , Frebourg T, Hannequin D, Campion D, Nicolas G.

Brain. 2019 Jun 1;142(6):1573-1586. doi: 10.1093/brain/awz095.

PMID:
31009047
6.

[Anticipating changes and risks in adults - From label to delivery of an innovative treatment: what a journey! (2)].

Antoine JC.

Med Sci (Paris). 2019 Mar;35 Hors série n° 1:35-36. doi: 10.1051/medsci/2019025. Epub 2019 Apr 3. French. No abstract available.

PMID:
30943160
7.

Completing the Immunological Fingerprint by Refractory Proteins: Autoantibody Screening via an Improved Immunoblotting Technique.

Moritz CP, Tholance Y, Rosier C, Reynaud-Federspiel E, Svahn J, Camdessanché JP, Antoine JC.

Proteomics Clin Appl. 2019 Jul;13(4):e1800157. doi: 10.1002/prca.201800157. Epub 2019 Mar 4.

PMID:
30768763
8.

Reducing the risk of misdiagnosis of indirect ELISA by normalizing serum-specific background noise: The example of detecting anti-FGFR3 autoantibodies.

Moritz CP, Tholance Y, Lassablière F, Camdessanché JP, Antoine JC.

J Immunol Methods. 2019 Mar;466:52-56. doi: 10.1016/j.jim.2019.01.004. Epub 2019 Jan 14.

PMID:
30654043
9.

Phrenic Nerve Conduction in Healthy Subjects.

Vincent M, Court-Fortune I, Costes F, Antoine JC, Camdessanché JP.

Muscle Nerve. 2019 Apr;59(4):451-456. doi: 10.1002/mus.26414. Epub 2019 Jan 24.

PMID:
30623462
10.

EEG analysis in anti-NMDA receptor encephalitis: Description of typical patterns.

Jeannin-Mayer S, André-Obadia N, Rosenberg S, Boutet C, Honnorat J, Antoine JC, Mazzola L.

Clin Neurophysiol. 2019 Feb;130(2):289-296. doi: 10.1016/j.clinph.2018.10.017. Epub 2018 Nov 29.

PMID:
30611120
11.

Isolated seizures are a common early feature of paraneoplastic anti-GABAB receptor encephalitis.

Maureille A, Fenouil T, Joubert B, Picard G, Rogemond V, Pinto AL, Thomas L, Ducray F, Quadrio I, Psimaras D, Berzero G, Antoine JC, Desestret V, Honnorat J.

J Neurol. 2019 Jan;266(1):195-206. doi: 10.1007/s00415-018-9132-0. Epub 2018 Nov 20.

PMID:
30460450
12.

Intravenous immunoglobulin for treatment of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in France: are daily practices in accordance with guidelines?

Rosier C, Graveline N, Lacour A, Antoine JC, Camdessanché JP.

Eur J Neurol. 2019 Apr;26(4):575-580. doi: 10.1111/ene.13841. Epub 2018 Nov 15.

PMID:
30326184
13.

Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies.

Bost C, Chanson E, Picard G, Meyronet D, Mayeur ME, Ducray F, Rogemond V, Psimaras D, Antoine JC, Delattre JY, Desestret V, Honnorat J.

J Neurol. 2018 Oct;265(10):2190-2200. doi: 10.1007/s00415-018-8970-0. Epub 2018 Jul 12.

PMID:
30003358
14.

Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study.

Hachulla E, Le Masson G, Solé G, Hamidou M, Desnuelle C, Azulay JP, Besson G, Swiader L, Abad S, Antoine JC, Bouhour F, Créange A, Grenouillet M, Magy L, Marcel S, Paquet JM, Rouhart F, Ziegler F, Mathis S, Gauthier-Darnis M, Puget S.

Biomed Res Int. 2018 Mar 15;2018:8147251. doi: 10.1155/2018/8147251. eCollection 2018.

15.

Encephalitis with mGluR5 antibodies: Symptoms and antibody effects.

Spatola M, Sabater L, Planagumà J, Martínez-Hernandez E, Armangué T, Prüss H, Iizuka T, Caparó Oblitas RL, Antoine JC, Li R, Heaney N, Tubridy N, Munteis Olivas E, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2018 May 29;90(22):e1964-e1972. doi: 10.1212/WNL.0000000000005614. Epub 2018 Apr 27.

16.

Initial clinical presentation of young children with N-methyl-d-aspartate receptor encephalitis.

Favier M, Joubert B, Picard G, Rogemond V, Thomas L, Rheims S, Bailhache M, Villega F, Pédespan JM, Berzero G, Psimaras D, Antoine JC, Desestret V, Honnorat J.

Eur J Paediatr Neurol. 2018 May;22(3):404-411. doi: 10.1016/j.ejpn.2017.12.014. Epub 2017 Dec 28.

PMID:
29310866
17.

Lethal form of spinocerebellar ataxia type 7 with early onset in childhood.

Gousse G, Patural H, Touraine R, Chabrier S, Rolland E, Antoine JC, Perrin L.

Arch Pediatr. 2018 Jan;25(1):42-44. doi: 10.1016/j.arcped.2017.09.029. Epub 2017 Dec 13.

PMID:
29248324
18.

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies.

Berzero G, Karantoni E, Dehais C, Ducray F, Thomas L, Picard G, Rogemond V, Candelier G, Camdessanché JP, Antoine JC, De Seze J, Liou-Schischmanoff A, Honnorat J, Delattre JY, Psimaras D.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):789-792. doi: 10.1136/jnnp-2017-316904. Epub 2017 Oct 30. No abstract available.

19.

Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features.

Svahn J, Petiot P, Antoine JC, Vial C, Delmont E, Viala K, Steck AJ, Magot A, Cauquil C, Zarea A, Echaniz-Laguna A, Iancu Ferfoglia R, Gueguen A, Magy L, Léger JM, Kuntzer T, Ferraud K, Lacour A, Camdessanché JP; Francophone anti-MAG cohort Group.

J Neurol Neurosurg Psychiatry. 2018 May;89(5):499-505. doi: 10.1136/jnnp-2017-316715. Epub 2017 Oct 25.

PMID:
29070644
20.

Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.

Hamidou B, Marin B, Lautrette G, Nicol M, Camu W, Corcia P, Arnes-Bes MC, Tranchant C, Clavelou P, Hannequin D, Maurice G, Beauvais K, Antoine JC, Danel-Brunaud V, Viader F, Preux PM, Couratier P.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):519-527. doi: 10.1080/21678421.2017.1353098. Epub 2017 Aug 1.

PMID:
28762856
21.

Paraneoplastic neuropathies.

Antoine JC, Camdessanché JP.

Curr Opin Neurol. 2017 Oct;30(5):513-520. doi: 10.1097/WCO.0000000000000475. Review.

PMID:
28682959
22.

Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis.

Joubert B, Gobert F, Thomas L, Saint-Martin M, Desestret V, Convers P, Rogemond V, Picard G, Ducray F, Psimaras D, Antoine JC, Delattre JY, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 14;4(4):e371. doi: 10.1212/NXI.0000000000000371. eCollection 2017 Jul.

23.

Home care organization impacts patient management and survival in ALS.

Lavernhe S, Antoine JC, Court-Fortune I, Dimier N, Costes F, Lacour A, Camdessanché JP.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):562-568. doi: 10.1080/21678421.2017.1332076. Epub 2017 Jun 6.

PMID:
28585472
24.

Hereditary neuropathy with liability to pressure palsy in patients under 30 years old: Neurophysiological data and proposed electrodiagnostic criteria.

Robert-Varvat F, Jousserand G, Bouhour F, Vial C, Cintas P, Echaniz-Laguna A, Delmont E, Clavelou P, Chauplannaz G, Jomir L, Pereon Y, Leonard-Louis S, Manel V, Antoine JC, Lacour A, Camdessanche JP.

Muscle Nerve. 2018 Feb;57(2):217-221. doi: 10.1002/mus.25666. Epub 2017 Jun 11.

PMID:
28407266
25.

Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies.

Do LD, Chanson E, Desestret V, Joubert B, Ducray F, Brugière S, Couté Y, Formaglio M, Rogemond V, Thomas-Antérion C, Borrega L, Laurens B, Tison F, Curot J, De Brouker T, Lebrun-Frenay C, Delattre JY, Antoine JC, Honnorat J.

Neurology. 2017 Feb 7;88(6):514-524. doi: 10.1212/WNL.0000000000003586. Epub 2017 Jan 6.

PMID:
28062719
26.

Anti-N-methyl-D-aspartate receptor encephalitis after Herpes simplex virus-associated encephalitis: an emerging disease with diagnosis and therapeutic challenges.

Schein F, Gagneux-Brunon A, Antoine JC, Lavernhe S, Pillet S, Paul S, Frésard A, Boutet C, Grange R, Cazorla C, Lucht F, Botelho-Nevers E.

Infection. 2017 Aug;45(4):545-549. doi: 10.1007/s15010-016-0959-y. Epub 2016 Nov 8.

PMID:
27826871
27.

Neuroleptic intolerance in patients with anti-NMDAR encephalitis.

Lejuste F, Thomas L, Picard G, Desestret V, Ducray F, Rogemond V, Psimaras D, Antoine JC, Delattre JY, Groc L, Leboyer M, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2016 Aug 29;3(5):e280. doi: 10.1212/NXI.0000000000000280. eCollection 2016 Oct.

28.

Safety and efficacy of a 6-month home-based exercise program in patients with facioscapulohumeral muscular dystrophy: A randomized controlled trial.

Bankolé LC, Millet GY, Temesi J, Bachasson D, Ravelojaona M, Wuyam B, Verges S, Ponsot E, Antoine JC, Kadi F, Féasson L.

Medicine (Baltimore). 2016 Aug;95(31):e4497. doi: 10.1097/MD.0000000000004497.

29.

Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures.

Joubert B, Saint-Martin M, Noraz N, Picard G, Rogemond V, Ducray F, Desestret V, Psimaras D, Delattre JY, Antoine JC, Honnorat J.

JAMA Neurol. 2016 Sep 1;73(9):1115-24. doi: 10.1001/jamaneurol.2016.1585.

PMID:
27428927
30.

Genetic analysis of CHCHD10 in French familial amyotrophic lateral sclerosis patients.

Teyssou E, Chartier L, Albert M, Bouscary A, Antoine JC, Camdessanché JP, Rotolo F, Couratier P, Salachas F, Seilhean D, Millecamps S.

Neurobiol Aging. 2016 Jun;42:218.e1-3. doi: 10.1016/j.neurobiolaging.2016.03.022. Epub 2016 Mar 24.

PMID:
27095681
31.

A case of anti-NMDA receptor encephalitis in a woman with a NMDA-R(+) small cell lung carcinoma (SCLC).

Jeraiby M, Depincé-Berger A, Bossy V, Antoine JC, Paul S.

Clin Immunol. 2016 May;166-167:96-9. doi: 10.1016/j.clim.2016.03.011. Epub 2016 Mar 25.

PMID:
27019996
32.

Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients.

Durel CA, Marignier R, Maucort-Boulch D, Iwaz J, Berthoux E, Ruivard M, André M, Le Guenno G, Pérard L, Dufour JF, Turcu A, Antoine JC, Camdessanche JP, Delboy T, Sève P.

J Neurol. 2016 May;263(5):981-990. doi: 10.1007/s00415-016-8092-5. Epub 2016 Mar 23.

PMID:
27007482
33.

Autoimmune encephalitis: paving the way for early diagnosis.

Antoine JC.

Lancet Neurol. 2016 Apr;15(4):349-50. doi: 10.1016/S1474-4422(16)00025-9. Epub 2016 Feb 20. No abstract available.

PMID:
26906965
34.

Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres.

Marin B, Beghi E, Vial C, Bernard E, Lautrette G, Clavelou P, Guy N, Lemasson G, Debruxelles S, Cintas P, Antoine JC, Camdessanche JP, Logroscino G, Preux PM, Couratier P; EURECALS consortium.

Eur J Neurol. 2016 Apr;23(4):787-95. doi: 10.1111/ene.12941. Epub 2016 Feb 1.

PMID:
26833536
35.

Identifying a therapeutic window in acute and subacute inflammatory sensory neuronopathies.

Antoine JC, Robert-Varvat F, Maisonobe T, Créange A, Franques J, Mathis S, Delmont E, Kuntzer T, Lefaucheur JP, Pouget J, Viala K, Desnuelle C, Echaniz-Laguna A, Rotolo F, Camdessanché JP; French Neuromuscular Network FILNEMUS.

J Neurol Sci. 2016 Feb 15;361:187-91. doi: 10.1016/j.jns.2015.12.044. Epub 2015 Dec 29.

PMID:
26810539
36.

Visual Assessment of Age-Related White Matter Hyperintensities Using FLAIR Images at 3 T: Inter- and Intra-Rater Agreement.

Boutet C, Rouffiange-Leclair L, Schneider F, Camdessanché JP, Antoine JC, Barral FG.

Neurodegener Dis. 2016;16(3-4):279-83. doi: 10.1159/000441420. Epub 2015 Dec 9.

PMID:
26646220
37.

CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis.

Desestret V, Chefdeville A, Viaccoz A, Bost C, Ducray F, Picard G, Rogemond V, Chaffois MO, Blanc C, Bardel C, Treilleux I, Pascual O, Antoine JC, Delattre JY, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2015 Oct 29;2(6):e166. doi: 10.1212/NXI.0000000000000166. eCollection 2015 Dec.

38.

Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature.

Joubert B, Kerschen P, Zekeridou A, Desestret V, Rogemond V, Chaffois MO, Ducray F, Larrue V, Daubail B, Idbaih A, Psimaras D, Antoine JC, Delattre JY, Honnorat J.

JAMA Neurol. 2015 Oct;72(10):1163-9. doi: 10.1001/jamaneurol.2015.1715. Review.

PMID:
26280228
39.

A retrospective study on the efficacy and safety of intraveinous immunoglobulin (Tegeline®) in patients with chronic inflammatory demyelinating polyneuropathy.

Robert F, Edan G, Nicolas G, Pouget J, Vial C, Antoine JC, Puget S.

Presse Med. 2015 Jul-Aug;44(7-8):e291-300. doi: 10.1016/j.lpm.2014.10.021. Epub 2015 Jun 9.

PMID:
26071027
40.

Treatment and outcome of children and adolescents with N-methyl-D-aspartate receptor encephalitis.

Zekeridou A, Karantoni E, Viaccoz A, Ducray F, Gitiaux C, Villega F, Deiva K, Rogemond V, Mathias E, Picard G, Tardieu M, Antoine JC, Delattre JY, Honnorat J.

J Neurol. 2015 Aug;262(8):1859-66. doi: 10.1007/s00415-015-7781-9. Epub 2015 May 19.

PMID:
25987208
41.

Somatosensory evoked potentials in the assessment of peripheral neuropathies: Commented results of a survey among French-speaking practitioners and recommendations for practice.

Morizot-Koutlidis R, André-Obadia N, Antoine JC, Attarian S, Ayache SS, Azabou E, Benaderette S, Camdessanché JP, Cassereau J, Convers P, d'Anglejean J, Delval A, Durand MC, Etard O, Fayet G, Fournier E, Franques J, Gavaret M, Guehl D, Guerit JM, Krim E, Kubis N, Lacour A, Lozeron P, Mauguière F, Merle PE, Mesrati F, Mutschler V, Nicolas G, Nordine T, Pautot V, Péréon Y, Petiot P, Pouget J, Praline J, Salhi H, Trébuchon A, Tyvaert L, Vial C, Zola JM, Zyss J, Lefaucheur JP.

Neurophysiol Clin. 2015 May;45(2):131-42. doi: 10.1016/j.neucli.2015.04.001. Epub 2015 May 6.

PMID:
25957985
42.

Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy.

Antoine JC, Boutahar N, Lassablière F, Reynaud E, Ferraud K, Rogemond V, Paul S, Honnorat J, Camdessanché JP.

J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1347-55. doi: 10.1136/jnnp-2014-309730. Epub 2015 Jan 27.

PMID:
25628376
43.

Pathophysiology and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathies.

Svahn J, Antoine JC, Camdessanché JP.

Rev Neurol (Paris). 2014 Dec;170(12):808-17. doi: 10.1016/j.neurol.2014.10.009. Epub 2014 Nov 6. Review.

PMID:
25459126
44.

[Editorial].

Antoine JC, Liblau R, Lubetzki C.

Rev Neurol (Paris). 2014 Oct;170(10):559-60. doi: 10.1016/j.neurol.2014.09.001. French. No abstract available.

PMID:
25280980
45.

[Sensory neuronopathy: diagnostic strategy].

Camdessanché JP, Antoine JC.

Presse Med. 2014 Nov;43(11):1185-8. doi: 10.1016/j.lpm.2014.02.034. Epub 2014 Sep 4. French.

PMID:
25201592
46.

Peripheral neuropathies associated with antibodies directed to intracellular neural antigens.

Antoine JC.

Rev Neurol (Paris). 2014 Oct;170(10):570-6. doi: 10.1016/j.neurol.2014.07.002. Epub 2014 Sep 4.

PMID:
25194475
47.

Acute neurological worsening after Rituximab treatment in patients with anti-MAG neuropathy.

Sala E, Robert-Varvat F, Paul S, Camdessanché JP, Antoine JC.

J Neurol Sci. 2014 Oct 15;345(1-2):224-7. doi: 10.1016/j.jns.2014.07.055. Epub 2014 Aug 2.

PMID:
25115501
48.

Testing the validity of a set of diagnostic criteria for sensory neuronopathies: a francophone collaborative study.

Antoine JC, Robert-Varvat F, Maisonobe T, Créange A, Franques J, Mathis S, Delmont E, Kuntzer T, Lefaucheur JP, Pouget J, Viala K, Desnuelle C, Echaniz-Laguna A, Rotolo F, Camdessanché JP; French CIDP study group.

J Neurol. 2014 Nov;261(11):2093-100. doi: 10.1007/s00415-014-7423-7. Epub 2014 Aug 10.

PMID:
25108558
49.

Brain magnetic resonance imaging findings in cryptogenic stroke patients under 60 years with patent foramen ovale.

Boutet C, Rouffiange-Leclair L, Garnier P, Quenet S, Delsart D, Varvat J, Epinat M, Schneider F, Antoine JC, Mismetti P, Barral FG.

Eur J Radiol. 2014 May;83(5):824-8. doi: 10.1016/j.ejrad.2014.01.022. Epub 2014 Feb 7.

PMID:
24582173
50.

Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience.

Ducray F, Demarquay G, Graus F, Decullier E, Antoine JC, Giometto B, Psimaras D, Delattre JY, Carpentier AF, Honnorat J.

Eur J Neurol. 2014 May;21(5):731-5. doi: 10.1111/ene.12368. Epub 2014 Jan 28.

PMID:
24471811

Supplemental Content

Loading ...
Support Center